Holen Sie sich die Stockscreener-App
137.64
2.27%
-3.19
Vorhandelsmarkt:
139.00
1.36
+0.99%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$140.83
Offen:
$140
24-Stunden-Volumen:
1.49M
Relative Volume:
1.40
Marktkapitalisierung:
$9.20B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
12.82
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
+23.79%
1M Leistung:
+23.50%
6M Leistung:
+6.29%
1J Leistung:
-20.71%
1-Tages-Spanne:
$136.19
$141.50
1-Wochen-Bereich:
$125.00
$151.42
52-Wochen-Spanne:
$101.00
$178.38
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, UHS, ENSG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
137.64 | 9.41B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
497.54 | 114.48B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
192.96 | 17.70B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.89 | 13.96B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
212.94 | 13.66B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
199.29 | 11.49B | 4.11B | 239.98M | 193.10M | 4.12 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Palmetto Grain Brokerage - Palmetto Grain Brokerage
DaVita Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call - TradingView
2 Warren Buffett Stocks to Buy Hand Over Fist in 2026 and 1 to Avoid - The Motley Fool
DaVita Dipped 6% After Big Run-Up: Why Analysts See a Path to $210 in 2026 - TIKR.com
DaVita (DVA) Surges as Top Healthcare Gainer in S&P 500 - GuruFocus
DaVita (DVA) Is Up 28.8% After Strong 2026 Guidance And Heavy BuybacksWhat's Changed - simplywall.st
Guidance Update: Will DaVita Inc stock benefit from M AMarket Risk Report & Weekly Chart Analysis and Guides - baoquankhu1.vn
DaVita, Elara deal could signal new take on kidney, home care - Modern Healthcare News
DaVita (NYSE:DVA) Shares Down 4.5%Time to Sell? - MarketBeat
Even With A 30% Surge, Cautious Investors Are Not Rewarding DaVita Inc.'s (NYSE:DVA) Performance Completely - simplywall.st
DaVita Inc. $DVA Shares Sold by Allianz Asset Management GmbH - MarketBeat
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita Inc. (NYSE:DVA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
DaVita Links IKC Profitability With Elara Home Care To Recast Growth - Yahoo Finance
DaVita (DVA) Margin Compression To 5.3% Challenges Bullish Valuation Narratives - Sahm
Here's why you should hold DaVita stock in your portfolio for now - MSN
DaVita stock price pops again as 2026 outlook fuels fresh Wall Street targets - TechStock²
UBS Raises Price Target for DaVita (DVA) to $190, Maintains Buy Rating | DVA Stock News - GuruFocus
DaVita Projects Significant EPS Growth Amid Strategic Expansion - StocksToTrade
DaVita stock price target raised to $190 from $186 at UBS on growth outlook - Investing.com Australia
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and DaVita (DVA) - The Globe and Mail
Lawsuit Investigation: Did DaVita Violate Patients’ Online Privacy? - ClassAction.org
Why Is DaVita (DVA) Stock Rocketing Higher Today - The Globe and Mail
DVA Q4 Deep Dive: Clinical Initiatives and Integrated Care Drive Outlook Amid Margin Compression - The Globe and Mail
Dallas Team Featured as Litigator of the Week - Winston & Strawn
Research Alert: CFRA Maintains Hold View On Shares Of Davita Inc. - 富途牛牛
Is DaVita stock underperforming the Dow? - MSN
Ares, DaVita to invest in home health provider Elara Caring By Investing.com - Investing.com India
DaVita Home Care Partnership Puts Valuation And Risk Profile In Focus - Sahm
DaVita’s Q4 Earnings Triumph Sparks Market Interest - timothysykes.com
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita (DVA) Shares Surge on Strong Q4 Results and Optimistic 20 - GuruFocus
DaVita Stock Surges as Q4 Earnings Exceed Expectations - StocksToTrade
DaVita Celebrates Strong Earnings as Strategic Investments Boost Future Outlook - timothysykes.com
Ares, DaVita Make Strategic Investment in Elara Caring - Hospice News
DaVita climbs as Q4 beat outshines Berkshire Hathaway insider sale - Seeking Alpha
Explore DaVita Within Dow Jones Industrial Average Healthcare Space - Kalkine Media
DaVita (DVA) Shares Surge Over 21% Amid Market Moves - GuruFocus
DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next - TechStock²
What Sent DaVita Stock Soaring On Tuesday? - Finviz
DaVita Inc Stock Soars 25% After DaVita Beats Q4 Results And Raises 2026 Outlook - Nasdaq
DaVita Stock Rallies On Profit Beat, Confident 2026 View - Benzinga
DaVita Stock Soars as Q4 Earnings and Strategy Surpass Expectations - StocksToTrade
Silver Surges Over 15%; Pfizer Earnings Top Views - Benzinga
Short Interest in DaVita Inc. (NYSE:DVA) Decreases By 14.2% - MarketBeat
DaVita’s Remarkable Financial Surge Surpasses Analysts’ Expectations - timothysykes.com
TD Cowen reiterates Hold rating on DaVita stock with $133 price target - Investing.com
DaVita (DVA) Soars Over 23% Amid Positive Market Movement - GuruFocus
DaVita: Some Success Is Possible, But Volatility Is Still Heavy (NYSE:DVA) - Seeking Alpha
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):